101 related articles for article (PubMed ID: 2559892)
1. Immune status of volunteers one year after administration of Japanese encephalitis vaccine produced in India.
Saxena SN; Bhau LN; Singh G; Gowal D; Sood YK; Misra CN; Das BK
Indian J Med Res; 1989 Nov; 89():362-7. PubMed ID: 2559892
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of effectiveness of mouse brain inactivated Japanese encephalitis vaccine produced in India.
Gowal D; Tahlan AK
Indian J Med Res; 1995 Dec; 102():267-71. PubMed ID: 8557319
[TBL] [Abstract][Full Text] [Related]
3. Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.
Erra EO; Askling HH; Yoksan S; Rombo L; Riutta J; Vene S; Lindquist L; Vapalahti O; Kantele A
Vaccine; 2013 Dec; 32(1):119-23. PubMed ID: 24176496
[TBL] [Abstract][Full Text] [Related]
4. Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis.
Paulke-Korinek M; Kollaritsch H; Kundi M; Zwazl I; Seidl-Friedrich C; Jelinek T
Vaccine; 2015 Jul; 33(30):3600-4. PubMed ID: 26036947
[TBL] [Abstract][Full Text] [Related]
5. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
6. Neutralizing antibody responses to Japanese encephalitis vaccine in children.
Juang RF; Okuno Y; Fukunaga T; Tadano M; Fukai K; Baba K; Tsuda N; Yamada A; Yabuuchi H
Biken J; 1983 Mar; 26(1):25-34. PubMed ID: 6626137
[TBL] [Abstract][Full Text] [Related]
7. Effect of current Japanese encephalitis vaccine on different strains of Japanese encephalitis virus.
Okuno Y; Okamoto Y; Yamada A; Baba K; Yabuuchi H
Vaccine; 1987 Jun; 5(2):128-32. PubMed ID: 3037813
[TBL] [Abstract][Full Text] [Related]
8. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers.
Van Gessel Y; Klade CS; Putnak R; Formica A; Krasaesub S; Spruth M; Cena B; Tungtaeng A; Gettayacamin M; Dewasthaly S
Vaccine; 2011 Aug; 29(35):5925-31. PubMed ID: 21723353
[TBL] [Abstract][Full Text] [Related]
9. Enzyme-linked immunosorbent assay for detection of serum antibody in children vaccinated with Japanese encephalitis vaccine.
Okamoto Y; Okuno Y; Yamada A; Baba K; Yabuuchi H
Biken J; 1986 Dec; 29(3-4):57-62. PubMed ID: 3619879
[TBL] [Abstract][Full Text] [Related]
10. Long-term Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine in Toddlers and Booster Response 5 Years After Primary Immunization.
Kosalaraksa P; Watanaveeradej V; Pancharoen C; Capeding MR; Feroldi E; Bouckenooghe A
Pediatr Infect Dis J; 2017 Apr; 36(4):e108-e113. PubMed ID: 28030526
[TBL] [Abstract][Full Text] [Related]
11. Serological response to Japanese encephalitis vaccine in a group of school children in South Arcot district of Tamil Nadu.
Mohan Rao CV; Risbud AR; Dandawate CN; Umarani UB; Ayachit VM; Rodrigues FM; Pavri KM
Indian J Med Res; 1993 Mar; 97():53-9. PubMed ID: 8505074
[TBL] [Abstract][Full Text] [Related]
12. Is a booster dose necessary in children after immunization with live attenuated Japanese encephalitis vaccine?
Choi UY; Lee SY; Kim KH; Kim DS; Choi KM; Cha SH; Kang JH
J Trop Pediatr; 2013 Oct; 59(5):423-5. PubMed ID: 23764540
[TBL] [Abstract][Full Text] [Related]
13. Japanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy.
Puthanakit T; Aurpibul L; Yoksan S; Sirisanthana T; Sirisanthana V
Vaccine; 2007 Nov; 25(49):8257-61. PubMed ID: 17964009
[TBL] [Abstract][Full Text] [Related]
14. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
Zhou B; Jia L; Xu X
Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
[TBL] [Abstract][Full Text] [Related]
15. Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine.
Konishi E; Yamaoka M; Kurane I; Mason PW
Virology; 2000 Mar; 268(1):49-55. PubMed ID: 10683326
[TBL] [Abstract][Full Text] [Related]
16. Immunizing children aged 9 to 15 months with live attenuated SA14-14-2 Japanese encephalitis vaccine in Thailand.
Chotpitayasunondh T; Sohn YM; Yoksan S; Min J; Ohrr H
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S195-203. PubMed ID: 22043776
[TBL] [Abstract][Full Text] [Related]
17. A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses.
Sohn YM; Tandan JB; Yoksan S; Ji M; Ohrr H
Vaccine; 2008 Mar; 26(13):1638-43. PubMed ID: 18294743
[TBL] [Abstract][Full Text] [Related]
18. Failure of Japanese encephalitis vaccine and infection in inducing neutralizing antibodies against West Nile virus, People's Republic of China.
Tang F; Zhang JS; Liu W; Zhao QM; Zhang F; Wu XM; Yang H; Ly H; Cao WC
Am J Trop Med Hyg; 2008 Jun; 78(6):999-1001. PubMed ID: 18541783
[TBL] [Abstract][Full Text] [Related]
19. Neutralizing antibody responses to Japanese encephalitis vaccine in children.
Juang RF; Fukai K
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1983 Sep; 16(3):190-7. PubMed ID: 6680096
[TBL] [Abstract][Full Text] [Related]
20. Neutralization antibody responses induced by Japanese encephalitis virus vaccine.
Susilowati S; Okuno Y; Fukunaga T; Tadano M; Juang RF; Fukai K
Biken J; 1981 Dec; 24(4):137-45. PubMed ID: 7346039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
